Company intelligence / Profile preview

BioEcho Life Sciences

Cologne, North Rhine-Westphalia, Germany

Ownership: Private
Development stage: Other

Overview

BioEcho Life Sciences develops and commercializes EchoLUTION single-step nucleic acid purification kits and related reagents for DNA and RNA extraction, cleanup, and viral nucleic acid preparation that are used in research, molecular diagnostics workflows, and biopharmaceutical R&D; it does not develop therapeutic drugs itself.

Modalities: Not applicable
Industry: Chemicals & Materials

Partnerships

Ampersand Capital Partners (growth equity investor/partner)Various diagnostic laboratories and research institutes using EchoLUTION technology (not individually named)

Beyond the preview

Go deeper on BioEcho Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioEcho Life Sciences.

Explore the full profile